Similarly, miR-3928 inhibits tumor growth and induces apoptosis in OS cells by targeting CDK6, IL-6R and ERBB3 genes, which encode the cyclin-dependent kinase 6, IL-6 receptor and tyrosine protein kinase receptor [52]. Here, CDK6 is linked to neoplasm.